
Dr.Anil Khurana Dy. Director General, CCRH, inaugurating a Research Unit on Homoeopathic Drug Pathogenetic Trials at JIMS, Homoeopathic Medical College & Hospital, Hyderabad, Telangana

Dr.Pritha Mehra Research Officer (H) Inaugurating workstation of Research unit

Dr.Pritha Mehra, at Museum Dept of Organon of Medicine of Dr.K.Raghuramchandra Looks on

Dr. Anil Khurana & Dr.Pritha Mehra Observing a rare specimen of lung showing maggots In the Museum of Forensic Medicine & Toxicology

Dr.Arvind Kothe Director JIMS-HMC & H explaining about infrastructure of Pharmacy Lab Dr.Anil Khurana & Dr.Pritha Mehra.Dr K.Raghuramchandra, Dr.Pravas Pal & Dr.Mahesh Kakada looks on

Dr.Anil Khurana & Dr.Pritha Mehra interacting with Faculty in Museum of Homoeopathic Pharmacy

Participants of workshop” Homoeopathic Drug Pathogenic Trial” at JIMS

Dr.Anil Khurana Deputy Director General Addressing at the workshop on Homoeopathic Pathogenic Trials at JIMS

Dr.Pritha Mehra, speaking at the Workshop” Homoeopathic Pathogenetic Trials”.